255 related articles for article (PubMed ID: 22461301)
1. Enzymatic processing of angiotensin peptides by human glomerular endothelial cells.
Velez JC; Ierardi JL; Bland AM; Morinelli TA; Arthur JM; Raymond JR; Janech MG
Am J Physiol Renal Physiol; 2012 Jun; 302(12):F1583-94. PubMed ID: 22461301
[TBL] [Abstract][Full Text] [Related]
2. Characterization of renin-angiotensin system enzyme activities in cultured mouse podocytes.
Velez JC; Bland AM; Arthur JM; Raymond JR; Janech MG
Am J Physiol Renal Physiol; 2007 Jul; 293(1):F398-407. PubMed ID: 17429035
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin I is largely converted to angiotensin (1-7) and angiotensin (2-10) by isolated rat glomeruli.
Velez JC; Ryan KJ; Harbeson CE; Bland AM; Budisavljevic MN; Arthur JM; Fitzgibbon WR; Raymond JR; Janech MG
Hypertension; 2009 May; 53(5):790-7. PubMed ID: 19289651
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism.
Rice GI; Thomas DA; Grant PJ; Turner AJ; Hooper NM
Biochem J; 2004 Oct; 383(Pt 1):45-51. PubMed ID: 15283675
[TBL] [Abstract][Full Text] [Related]
5. Critical Role of Neprilysin in Kidney Angiotensin Metabolism.
Kaltenecker CC; Domenig O; Kopecky C; Antlanger M; Poglitsch M; Berlakovich G; Kain R; Stegbauer J; Rahman M; Hellinger R; Gruber C; Grobe N; Fajkovic H; Eskandary F; Böhmig GA; Säemann MD; Kovarik JJ
Circ Res; 2020 Aug; 127(5):593-606. PubMed ID: 32418507
[TBL] [Abstract][Full Text] [Related]
6. Unraveling the glomerular RAS: one peptidase at a time.
Harrison-Bernard LM; Chappell MC
Am J Physiol Renal Physiol; 2012 Aug; 303(3):F373-4. PubMed ID: 22573374
[No Abstract] [Full Text] [Related]
7. Angiotensin metabolism in renal proximal tubules, urine, and serum of sheep: evidence for ACE2-dependent processing of angiotensin II.
Shaltout HA; Westwood BM; Averill DB; Ferrario CM; Figueroa JP; Diz DI; Rose JC; Chappell MC
Am J Physiol Renal Physiol; 2007 Jan; 292(1):F82-91. PubMed ID: 16896185
[TBL] [Abstract][Full Text] [Related]
8. Intrarenal alterations of the angiotensin-converting enzyme type 2/angiotensin 1-7 complex of the renin-angiotensin system do not alter the course of malignant hypertension in Cyp1a1-Ren-2 transgenic rats.
Husková Z; Kopkan L; Červenková L; Doleželová Š; Vaňourková Z; Škaroupková P; Nishiyama A; Kompanowska-Jezierska E; Sadowski J; Kramer HJ; Červenka L
Clin Exp Pharmacol Physiol; 2016 Apr; 43(4):438-49. PubMed ID: 26833491
[TBL] [Abstract][Full Text] [Related]
9. Effects of renin-angiotensin system blockade on renal angiotensin-(1-7) forming enzymes and receptors.
Ferrario CM; Jessup J; Gallagher PE; Averill DB; Brosnihan KB; Ann Tallant E; Smith RD; Chappell MC
Kidney Int; 2005 Nov; 68(5):2189-96. PubMed ID: 16221218
[TBL] [Abstract][Full Text] [Related]
10. Portal pressure responses and angiotensin peptide production in rat liver are determined by relative activity of ACE and ACE2.
Herath CB; Lubel JS; Jia Z; Velkoska E; Casley D; Brown L; Tikellis C; Burrell LM; Angus PW
Am J Physiol Gastrointest Liver Physiol; 2009 Jul; 297(1):G98-G106. PubMed ID: 19389807
[TBL] [Abstract][Full Text] [Related]
11. Neprilysin is a Mediator of Alternative Renin-Angiotensin-System Activation in the Murine and Human Kidney.
Domenig O; Manzel A; Grobe N; Königshausen E; Kaltenecker CC; Kovarik JJ; Stegbauer J; Gurley SB; van Oyen D; Antlanger M; Bader M; Motta-Santos D; Santos RA; Elased KM; Säemann MD; Linker RA; Poglitsch M
Sci Rep; 2016 Sep; 6():33678. PubMed ID: 27649628
[TBL] [Abstract][Full Text] [Related]
12. Identification of prolyl carboxypeptidase as an alternative enzyme for processing of renal angiotensin II using mass spectrometry.
Grobe N; Weir NM; Leiva O; Ong FS; Bernstein KE; Schmaier AH; Morris M; Elased KM
Am J Physiol Cell Physiol; 2013 May; 304(10):C945-53. PubMed ID: 23392115
[TBL] [Abstract][Full Text] [Related]
13. Brain angiotensin-converting enzymes: role of angiotensin-converting enzyme 2 in processing angiotensin II in mice.
Elased KM; Cunha TS; Marcondes FK; Morris M
Exp Physiol; 2008 May; 93(5):665-75. PubMed ID: 18263657
[TBL] [Abstract][Full Text] [Related]
14. New mass spectrometric assay for angiotensin-converting enzyme 2 activity.
Elased KM; Cunha TS; Gurley SB; Coffman TM; Morris M
Hypertension; 2006 May; 47(5):1010-7. PubMed ID: 16585421
[TBL] [Abstract][Full Text] [Related]
15. A novel mechanism for angiotensin II formation in streptozotocin-diabetic rat glomeruli.
Singh R; Singh AK; Leehey DJ
Am J Physiol Renal Physiol; 2005 Jun; 288(6):F1183-90. PubMed ID: 15701818
[TBL] [Abstract][Full Text] [Related]
16. Novel roles of the renal angiotensin-converting enzyme.
Giani JF; Veiras LC; Shen JZY; Bernstein EA; Cao D; Okwan-Duodu D; Khan Z; Gonzalez-Villalobos RA; Bernstein KE
Mol Cell Endocrinol; 2021 Jun; 529():111257. PubMed ID: 33781839
[TBL] [Abstract][Full Text] [Related]
17. Ang II (Angiotensin II) Conversion to Angiotensin-(1-7) in the Circulation Is POP (Prolyloligopeptidase)-Dependent and ACE2 (Angiotensin-Converting Enzyme 2)-Independent.
Serfozo P; Wysocki J; Gulua G; Schulze A; Ye M; Liu P; Jin J; Bader M; Myöhänen T; García-Horsman JA; Batlle D
Hypertension; 2020 Jan; 75(1):173-182. PubMed ID: 31786979
[TBL] [Abstract][Full Text] [Related]
18. Modulation of renal glomerular angiotensin II receptors by ace inhibition and AT1 receptor antagonism.
Haddad G; Amiri F; Garcia R
Regul Pept; 1997 Jan; 68(2):111-7. PubMed ID: 9110382
[TBL] [Abstract][Full Text] [Related]
19. Network modeling reveals steps in angiotensin peptide processing.
Schwacke JH; Spainhour JC; Ierardi JL; Chaves JM; Arthur JM; Janech MG; Velez JC
Hypertension; 2013 Mar; 61(3):690-700. PubMed ID: 23283355
[TBL] [Abstract][Full Text] [Related]
20. ACE and ACE2 in inflammation: a tale of two enzymes.
Gaddam RR; Chambers S; Bhatia M
Inflamm Allergy Drug Targets; 2014; 13(4):224-34. PubMed ID: 25019157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
